Structural and functional aspects of calcium binding in extracellular matrix proteins

Matrix Biology

Volumn 15, Issue 8-9, 1997, Pages 569-580

  Maurer, Patrik ^a   Hohenester, Erhard ^b  

^a UNIVERSITY OF COLOGNE   (Germany)

^b UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

Calcium binding sites; Extracellular proteins; Fibrillin; Hereditary human connective tissue disorders

Indexed keywords

CALCIUM BINDING PROTEIN; CALCIUM ION; FIBRILLIN; MATRIX PROTEIN; SCLEROPROTEIN;

ARTICLE; CALCIUM BINDING; CARTILAGE; CONNECTIVE TISSUE DISEASE; EXTRACELLULAR MATRIX; HUMAN; MARFAN SYNDROME; PHYSIOLOGY; POINT MUTATION; PRIORITY JOURNAL; STRUCTURE ACTIVITY RELATION;

EID: 0030888219     PISSN: 0945053X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0945-053X(97)90033-0     Document Type: Article

References (92)

1. Adams J., Lawler J. The thrombospondin family. Curr. Biol. 3:1993;188-190.
2. Al-Mutlaq H., Wheeler J., Robertson C., Watchom C., Morley A.R. Tissue distribution of amyloid P component as defined by monoclonal antibody produced by immunization with human glomerular basement membrane. Histochem. J. 25:1993;219-227.
3. Atkinson R.A., Evans J.S., Hauschka P.V., Levine B.A., Meats R., Triffitt J.T., Virdi A.S., Williams R.J.P. Conformational studies of osteocalcin in solution. Eur. J. Biochem. 232:1995;515-521.
4. Becker K.-F., Atkinson M.J., Reich U., Becker I., Nekarda H., Siewert J.R., Hofler H. E-cadherin gene mutations provide clues to diffuse type gastric carcinomas. Cancer Res. 54:1994;3845-3854.
5. Birchmeier W. E-cadherin as a tumor (invasion) suppressor gene. Bioessays. 17:1995;97-99.
6. Blundell T.L. Metalloproteinase superfamilies and drug design. Nature Struct. Biol. 1:1994;73-75.
7. Bode W. A helping hand for collagenases: the hemopexin-like domain. Structure. 3:1995;527-530.
8. Bode W., Gomis-Ruth F.-X., Stocker W. Astacins, serralysins, snake venom and matrix metalloproteinases exhibit identical zinc-binding environments (HEXXHXXGXXH and Metturn) and topologies and should be group into a common family, the 'metzincins'. FEBS Lett. 331:1993;134-140.
9. Bode W., Reinemer P., Huber R., Kleine T., Schnierer S., Tschesche H. The X-ray crystal structure of the catalytic domain of human neutrophil collagenase inhibited by a substrate analogue reveals the essentials for catalysis and specificity. EMBO J. 13:1994;1263-1269.
10. Borkakoti N., Winkler F.K., Williams D.H., D'Arcy A., Broadhurst M.J., Brown P.A., Johnson W.H., Murray E.J. Structure of the catalytic domain of human fibroblast collagenase complexed with an inhibitor. Nature Struct. Biol. 1:1994;106-110.
11. Bornstein P. Thrombospondins: structure and regulation of expression. FASEB J. 6:1992;3290-3299.
12. Breathnach S.M., Kofler H., Sepp N., Ashworth J., Woodrow D., Pepys M.B., Hintner H. Serum amyloid P component binds to cell nuclei in vitro and to in vivo deposits of extracellular chromatin in systemic lupus erythematosus. J. Exp. Med. 170:1989;1433-1438.
13. Breathnach S.M., Melrose S.M., Bhogal B., de Beer F.C., Dyck R.F., Tennent G., Black M.M., Pepys M.B. Amyloid P component is located on elastic fiber microfibrils in normal human tissue. Nature. 293:1981;652-654.
14. Briggs M.D., Hoffman S.M.G., King L.M., Olsen A.S., Mohrenweiser H., Leroy J.G., Mortier G.R., Rimoin D.L., Lachman R.S., Gaines E.S., Cekleniak J.A., Knowlton R.G., Cohn D.H. Pseudoachondroplasia and multiple epiphyseal dysplasia due to mutations in the cartilage oligomeric matrix protein gene. Nat. Genet. 10:1995;330-336.
15. 2+ ions as extracellular messengers. Cell. 83:1995;679-682.
16. Butler J.P.G., Tennent G.A., Pepys M.B. Pentraxin-chromatin interactions: serum amyloid P component specifically displaces H1-type histones and solubilizes native long chromatin. J. Exp. Med. 172:1989;13-18.
17. Campbell I.D., Bork P. Epidermal growth factor-like modules. Curr. Opin. Struct. Biol. 3:1993;385-392.
18. Cierniewski C.S., Haas T.A., Smith J.W., Plow E.E., Plow E.F. Characterization of cation-binding sequences in the platelet integrin GPIIb-IIIa by terbium luminescence. Biochemistry. 33:1994;12238-12246.
19. 2+ and is coded by cDNAs that reveal multidomain structure and alternatively spliced exons at the 5′ end. Genomics. 17:1993;476-484.
20. Davie E.W., Fujikawa K., Kisiel W. The coagulation cascade: initiation, maintenance and regulation. Biochemistry. 30:1991;10363-10367.
21. de Beer E.C., Baltz M.F., Holford S., Feinstein A., Pepys M.B. Fibronectin and C4-binding protein are selectively bound by aggregated amyloid P component. J. Exp. Med. 154:1981;1134-1149.
22. Dhanaraj V., Ye Q.-Z., Johnson L.L., Hupe D.J., Ortwine D.F., Dunbar J.B. Jr., Rubin J.R., Pavlowsky A., Humblet C., Blundell T.L. X-ray structure of a hydroxamate inhibitor complex of stromelysin catalytic domain and its comparison with members of the zinc metalloproteinase superfamily. Structure. 4:1996;375-386.
23. Dietz H.C., Pyeritz R.E. Mutations in the human gene for fibrillin-1 (FBN1) in the Marfan syndrome and related disorders. Hum. Mol. Gen. 4:1995;1799-1809.
24. Docherty A.J.P., O'Connell J., Crabbe T., Angal S., Murphy G. The matrix metalloproteinases and their natural inhibitors-prospects for treating degenerative tissue diseases. Trends Biotech. 10:1992;200-207.
25. Doolittle R.F. The multiplicity of domains in proteins. Ann. Rev. Biochem. 64:1995;315-343.
26. 2+-binding epidermal growth factor-like domains: implications for the Marfan Syndrome an other genetic disorders. Cell. 85:1996;597-605.
27. D'Souza S.E., Haas T.A., Piotrowicz R.S., Byers-Ward V., McGrath D.E., Soule H.R., Cierniewski C., Plow E.F., Smith J.W. Ligand and cation binding are duel functions of a discrete segment of the integrin β3 subunit: cation displacement is involved in ligand binding. Cell. 79:1994;659-667.
28. Dyck R.F., Lockwood C.M., Kershaw M., McHugh N., Duance V.C., Baltz M.L., Pepys M.B. Amyloid P component is a constituent of normal human glomerular basement membrane. J. Exp. Med. 152:1980;1162-1174.
29. Emsley J., White H.E., O'Hara B.P., Oliva G., Srinivasan N., Tickle I.J., Blundell T.L., Pepys M.B., Wood S.P. Structure of pentameric human serum amyloid P component. Nature. 367:1994;338-345.
30. Engel J. EGF-like domains in extracellular matrix proteins: localized signals for growth and differentiation? FEBS Lett. 251:1989;1-7.
31. Engel J., Efimov V.P., Maurer P. Domain organization of extracellular matrix proteins and their evolution. Development. 120:1994;35-42. Suppl.
32. 2+-induced conformational transition of SPARC/BM-40/osteonectin, an extracellular glycoprotein expressed in mineralized and nonmineralized tissues. Biochemistry. 26:1987;6958-6965.
33. Gewurz H., Zhang X.H., Lint T.L. Structure and function of the pentraxins. Curr. Opin. Immunol. 7:1995;54-64.
34. Ginsberg M.H. Integrins: dynamic regulation of ligand binding. Biochem. Soc. Trans. 23:1995;439-449.
35. Gooley P.R., O'Connell J.F., Marcy A.I., Cuca G.C., Salowe S.P., Bush B.L., Hermes J.D., Esser C.K., Hagmann W.K., Springer J.P., Johnson B.A. The NMR structure of the inhibited catalytic domain of human stromelysin-1. Nature Struct. Biol. 1:1994;111-118.
36. Gorski J.P. Acidic phosphoproteins from bone matrix: a structural rationalization of their role in biomineralization. Calcif. Tissue Int. 50:1992;391-396.
37. Grams F., Reinemer P., Powers J.C., Kleine T., Pieper M., Tschesche H., Huber R., Bode W. X-ray structures of human neutrophil collagenase complex with peptide hydroxamate and peptide thiol inhibitors: implications for substrate binding and rational drug design. Eur. J. Biochem. 228:1995;830-841.
38. 2+-binding properties of the platelet glycoprotein IIB ligand-interacting domain. J. Biol. Chem. 267:1992;1001-1007.
39. Haas T.A., Plow E.F. Integrin-ligand interactions: a year in review. Curr. Opin. Cell Biol. 6:1994;656-662.
40. 2+-mediated association of human serum amyloid P component with heparan sulfate and dermatan sulfate. J. Biol. Chem. 262:1987;1456-1460.
41. 2+-binding motifs in EGF-like domains. Nature. 351:1991;164-167.
42. Hauschka P.V., Lian J.B., Cole D.E.C., Gundberg C.M. Osteocalcin and matrix Gla protein: vitamin K-dependent proteins in bone. Physiol. Rev. 69:1989;990-1047.
43. 2+ receptor. Curr. Opin. Cell Biol. 7:1995;484-492.
44. Hecht J., Nelson I.D., Crowder E., Wang Y., Elder F.F.B., Harrison W.R., Francomano C.A., Prange C.K., Lennon G.G., Deere M., Lawler J. Mutations in exon 17B of cartilage oligomeric matrix protein (COMP) cause pseudoachondroplasia. Nat. Genet. 10:1995;325-329.
45. 2+-binding module in BM-40. Nature Struct. Biol. 3:1996;67-73.
46. Humphries M.J. Mechanisms of ligand binding by integrins. Biochem. Soc. Trans. 22:1994;275-282.
47. Kleiner D.E. Jr., Stetler-Stevenson L.A. Structural biochemistry and activation of matrix metalloproteases. Curr. Opin. Cell Biol. 5:1993;891-897.
48. 2+-binding properties of an epidermal growth factor-like domain pair from human fibrillin-1. J. Mol. Biol. 255:1996;22-27.
49. Koch W.W., Franke P.J. Desmosomal cadherins: another growing multigene family of adhesion molecules. Curr. Opin. Cell Biol. 6:1994;682-687.
50. Kraulis P.J. MOLSCRIPT: a program to produce both detailed and schematic plot of protein structures. J. Appl. Cryst. 24:1991;946-950.
51. Kretsinger R.H. EF-hands reach out. Nature Struct. Biology. 3:1996;12-15.
52. 2+-binding Proteins. 1991;17-37 Springer, Berlin.
53. Lane T.F., Sage H. The biology of SPARC, a protein that modulates cell-matrix interactions. FASEB J. 8:1994;163-173.
54. 2+ to thrombospondin. J. Biol. Chem. 258:1983;12098-12101.
55. Lee L.-O., Bankston L.A., Anaout M.A., Liddington R.C. Two conformations of the integrin A-domain (I-domain): a pathway for activation? Structure. 3:1995b;1333-1340.
56. Lee L.-O., Rieu P., Arnaout M.A., Liddington R. Crystal structure of the A domain from the a subunit of integrin CR3 (CD11b/CD18). Cell. 80:1995a;631-638.
57. 2+-linked four-bladed β-propeller. Structure. 3:1995;541-549.
58. Loftus J.C., Smith J.W., Ginsberg M.H. Integrin-mediated cell adhesion: the extracellular face. J. Biol. Chem. 269:1994;25235-25238.
59. Lovejoy B., Cleasby A., Hassell A.M., Longley K., Luther M.A., Weigl D., McGeehan G., McElroy A.B., Drewry D., Lambert M.M., Jordan S.R. Structure of the catalytic domain of fibroblast collagenase complexed with an inhibitor. Science. 263:1994;375-377.
60. 2+ and collagen. J. Mol. Biol. 253:1995;347-357.
61. 2+ binding and stability of the multidomain extracellular glycoprotein BM40/SPARC/osteonectin. Eur. J. Biochem. 205:1992;233-240.
62. Michishita M., Videm V., Arnaout M.A. A novel divalent cation-binding site in the A domain of the β2 integrin CR3 (CD11b/CD18) is essential for ligand binding. Cell. 72:1993;857-867.
63. 2+ ion binding to thrombospondin 1. J. Biol. Chem. 270:1995;1729-1733.
64. Mörgelin M., Heinegård D., Engel J., Paulsson M. Electron microscopy of native cartilage oligomeric matrix protein purified from the Swarm rat chondrosarcoma reveals a five-armed structure. J. Biol. Chem. 267:1992;6137-6141.
65. 2+-induced E-cadherin rigidification and dimerization. Nature. 380:1996;360-364.
66. 2+ and its functional implications. Fed. Proc. 39:1980;1519-1523.
67. Overduin M., Harvey T.S., Bagby S., Tong K.I., Yau P., Takeichi M., Ikura M. Solution structure of the epithelial cadherin domain responsible for selective cell adhesion. Science. 267:1995;386-389.
68. 2+-concentration. Biochemistry. 34:1995;9277-9281.
69. 2+-binding site of uvomorulin abolish the adhesive function. Cell. 63:1990;1033-1038.
70. Paulsson M., Aumailley M., Deutzmann R., Timpl R., Beck K., Engel J. Laminin-nidogen complex. Extraction with chelating agents and structural characterization. Eur. J. Biochem. 166:1987;11-19.
71. Pepys M.B., Rademacher T.W., Amatayakul-Chantler S., Williams P., Noble G.E., Hutchinson W.L., Hawkins P.N., Nelson S.R., Gallimore J.R., Herbert J., Hutton T., Dwek R.A. Human serum amyloid P component is an invariant constituent of amyloid deposits and has a uniquely homogeneous glycostructure. Proc. Natl. Acad. Sci. USA. 91:1994;5602-5606.
72. 2+-binding. Eur. J. Biochem. 223:1994;1019-1026.
73. 2+ and collagen IV binding caused by mutations in the EF-hand and other domains of extracellular matrix protein BM-40 (SPARC, osteonectin). J. Mol. Biol. 238:1994;563-574.
74. Pytela R. Amino acid sequence of murine Mac-1 α chain reveals homology with the integrin family and an additional domain related to von Willebrand factor. EMBO J. 7:1988;1371-1378.
75. Qu A., Leahy D.J. The role of the divalent cation in the structure of the I domain from the CD11a/CD18 integrin. Structure. 4:1996;931-942.
76. 2+-binding epidermal growth factor-like domain: its role in protein-protein interactions. Cell. 82:1995;131-141.
77. Rees D.J.G., Jones I.M., Handford P.A., Walter S.J., Esnouf M.P., Smith K.J., Brownlee G.G. The role of β-hydroxyaspartate and adjacent carboxylate residues in the first EGF domain of human factor IX. EMBO J. 7:1988;2053-2061.
78. Reid, K.: Matrix Biol., this issue.
79. 2+ binding to human platelet integrin gpIIb/IIIa and to its constituent glycoproteins. Biochem. J. 276:1991;35-40.
80. Shapiro L., Fannon A.M., Kwong P.D., Thompson A., Lehmann M.S., Gruebel G., Legrand J.F., Als-Nielsen J., Colman D.R., Hendrickson W.A. Structural basis of cell-cell adhesion by cadherins. Nature. 374:1995;327-337.
81. Stams T., Spurlino J.C., Smith D.L., Wahl R.C., Ho T.F., Qoronfleh M.W., Banks T.M., Rubin B. Structure of human neutrophil collagenase reveals large S1' specificity pocket. Nature Struct. Biol. 1:1994;119-123.
82. Stenflo J., Oehlin A.K., Persson E., Valcare C., Astermark J., Drakenberg T., Selander M., Linse S., Bjork I. Epidermal growth factor-like domains in the vitamin K-dependent clotting factors. Some structure-function relationships. Ann. NY Acad. Sci. 614:1991;11-29.
83. Stetler-Stevenson L.A., Kleiner D.E. Jr. Role of matrix metalloproteinases in tumor invasion and metastasis. FASEB J. 7:1993;1434-1441.
84. 2+-binding proteins. Ann. Rev. Biochem. 58:1989;951-998.
85. 2+-free GLA domain sheds light on membrane binding of blood coagulation proteins. Nature Struct. Biol. 6:1995;504-509.
86. Takeichi M. Morphogenetic roles of classic cadherins. Curr. Opin. Cell Biol. 7:1995;619-627.
87. Tennent G.A., Pepys M.B. Glycobiology of the pentraxins. Biochem. Soc. Trans. 22:1994;74-79.
88. Tennent G.A., Pepys M.B. Serum amyloid P component prevents proteolysis of the amyloid fibrils of Alzheimer disease and systemic amyloidosis. Proc. Natl. Acad. Sci. USA. 92:1995;4299-4303.
89. Tomschy A., Fauser C., Landwehr R., Engel J. Homophilic adhesion of E-cadherin occurs by a co-operative two-step interaction of N-terminal domains. EMBO J. 15:1996;3507-3514.
90. Tuckwell D.S., Humphries M.J., Brass A. A secondary structure model of the integrin alpha subunit N-terminal domain based on analyses of multiple alignments. Cell Adhes. Commun. 2:1994;385-402.
91. 2+-binding 63-kDa bone protein. J. Biol. Chem. 270:1995;6125-6133.
92. Woessner F. Matrix metalloproteinases and their inhibitors in connective tissue remodelling. FASEB J. 5:1991;2145-2154.